Trials / Conditions / Androgen-Resistant Prostatic Cancer
Androgen-Resistant Prostatic Cancer
3 registered clinical trials studyying Androgen-Resistant Prostatic Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant NCT05848011 | MacroGenics | Phase 2 |
| Terminated | A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and NCT05551117 | MacroGenics | Phase 2 |
| Terminated | Efficacy Evaluation of VERU-111 for mCRPC in Patients Who Have Failed at Least One Androgen Receptor Targeting NCT04844749 | Veru Inc. | Phase 3 |